Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer.
about
Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune TherapyGrowth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivoMolecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis.Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC).RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.Therapeutic concentrations of anti-epileptic drugs do not inhibit the activity of the oncolytic adenovirus Delta24-RGD in malignant glioma.Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion.Valproic acid stimulates proliferation of glial precursors during cortical gliogenesis in developing rat.The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258.
P2860
Q26783032-1971B2D2-F77C-41AA-9B49-2303C6261EFBQ33927370-584EDD24-FC86-4725-B985-44296E80C4AAQ34002839-01B40ABB-662C-4693-A4CC-26EC138F6389Q36867359-1BFF8CDD-D737-4F74-B9E5-ECB29E6FA404Q38161395-30669D7B-0142-4562-B625-C39C717F822BQ39162666-F4F8BCCD-2738-40B9-B28E-273F94D3AEA0Q39369865-2D1E7032-489F-4817-8FA5-5A352BC795C7Q40388690-7C66CF89-CBB3-4ADD-ADCC-367417A2BA90Q53156735-782840D0-576E-419E-8E6A-0763081290C2
P2860
Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Critical analysis of simultane ...... treatment of prostate cancer.
@en
Critical analysis of simultane ...... treatment of prostate cancer.
@nl
type
label
Critical analysis of simultane ...... treatment of prostate cancer.
@en
Critical analysis of simultane ...... treatment of prostate cancer.
@nl
prefLabel
Critical analysis of simultane ...... treatment of prostate cancer.
@en
Critical analysis of simultane ...... treatment of prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Critical analysis of simultane ...... treatment of prostate cancer.
@en
P2093
Axel Haferkamp
Elsie Oppermann
Eva Juengel
Jens-Michael Seibel
Lukasz Hudak
Roman A Blaheta
Steffen Wedel
P2860
P304
P356
10.1002/PROS.21288
P577
2010-10-15T00:00:00Z